The Instillo Group
The Instillo group, consolidates an independent group of companies which operates over 20 countries world wide. It has established a strong network and built up a competitive team offering their expert knowledge for a number of national and international companies in a trustworthy working environment. Through its partnership with the Instillo group, leon nanodrugs is the exclusive license owner of the MicroJet Reactor technology for all pharmaceutical applications for all dosage forms.
CoreRx® a CDMO with a focus on early phase drug product development, offering state of the art facilities to support your supply chain needs throughout the entire clinical trial process. Our integrated offerings provide comprehensive services for the development, manufacturing and testing of solid, liquid and semi-solid dosage forms.
The art of drug product development is the core of what we do. We differentiate ourselves by mixing highly experienced scientists with a wide range of technologies to deliver optimal solutions to meet our clients’ needs. From simple formulations to complex, delayed or targeted release dosage forms, CoreRx’s solutions maximize client investments, shorten development time and reduce overall costs.
At CoreRx, you bring us your formulation challenge and we will supply the right ingredients to ensure your product reaches its maximum potential.